Showing results (61-70 of 208) with videos related to
Sort By:
Pageof 21
Animals : an Open Access Journal From MDPI|December 9, 2023
Exploring the Effects of Acute Stress Exposure on Lumpfish Plasma and Liver BiomarkersTiago da Santa Lopes, Benjamin Costas, Lourenço Ramos-Pinto, et al.Pediatric Blood & Cancer|January 12, 2010
A feasibility trial of a video intervention to improve informed consent for parents of children with leukemiaRebecca A Hazen, Michelle Eder, Dennis Drotar, et al.Journal of Neuro-Oncology|May 6, 2014
Alternative lengthening of telomeres in neuroblastoma cell lines is associated with a lack of MYCN genomic amplification and with p53 pathway aberrationsAhsan S Farooqi, Rebecca A Dagg, L Mi Rim Choi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2006
Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children's Oncology Group (CCG 09709), Judith G Villablanca, Mark D Krailo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2008
Sodium thiosulfate administered six hours after cisplatin does not compromise antineuroblastoma activityTheresa M Harned, Ondrej Kalous, Alexander Neuwelt, et al.Cancer Research|October 3, 2007
The activity of zoledronic Acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferationHongjun Peng, Yasuyoshi Sohara, Rex A Moats, et al.Cancer Research|May 14, 2009
Comparison of primary neuroblastoma tumors and derivative early-passage cell lines using genome-wide single nucleotide polymorphism array analysisSamuel L Volchenboum, Cheng Li, Shuli Li, et al.Pediatric Blood & Cancer|September 26, 2018
Cytotoxic activity of difluoromethylornithine compared with fenretinide in neuroblastoma cell linesMonish R Makena, Hwang Eui Cho, Thinh H Nguyen, et al.Molecular Cancer Therapeutics|September 6, 2019
Fenretinide via NOXA Induction, Enhanced Activity of the BCL-2 Inhibitor Venetoclax in High BCL-2-Expressing Neuroblastoma Preclinical ModelsThinh H Nguyen, Balakrishna Koneru, Sung-Jen Wei, et al.Anti-Cancer Drugs|October 20, 2020
Vorinostat and fenretinide synergize in preclinical models of T-cell lymphoid malignanciesMonish Ram Makena, Thinh H Nguyen, Balakrishna Koneru, et al.Pageof 21